Antimicrobial activity data in support of nitrofurantoin three times per day

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 7, 2011, Pages 1652-1653

  Amábile Cuevas, Carlos F ^a   Arredondo García, José Luis ^b  

^a Fundacion LUSARA   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Escherichia coli; Minimal inhibitory concentration; Post antibiotic effect; Urinary tract infection

Indexed keywords

NITROFURANTOIN;

ANTIMICROBIAL ACTIVITY; BODY WEIGHT; CYSTITIS; DRUG EFFICACY; DRUG URINE LEVEL; HUMAN; INCUBATION TEMPERATURE; LETTER; LIQUID CULTURE; RECOMMENDED DRUG DOSE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ADULT; ANTI-INFECTIVE AGENTS, URINARY; BACTERIAL LOAD; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; NITROFURANTOIN; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 79958817891     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr170     Document Type: Letter

References (6)

1. Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J Antimicrob Chemother 2010; 65 Suppl 3: iii25-33.
2. Arredondo-García JL, Amábile-Cuevas CF. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City. J Infect Dev Ctries 2008; 2: 350-3.
3. Sandegren L, Lindqvist A, Kahlmeter G et al. Nitrofurantoin resistance mechanisms and fitness cost. J Antimicrob Chemother 2008; 62: 495-503.
4. Grayson ML, Whitby M. Nitrofurans: nitrofurazone, furazolidone and nitrofurantoin. In: Grayson ML, Crowe SM, McCarthy JS et al., eds. Kucers' The Use of Antibiotics, Sixth Edition. London: Hodder Arnold, 2010; 1195-204.
5. Guelen PJM, Boerema JBJ, Vree TB. Comparative human bioavailability study of macrocrystalline nitrofurantoin and two prolonged-action hydroxymethylnitrofurantoin preparations. Drug Intell Clin Pharm 1988; 22: 959-64.
6. Petri WA. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Brunton LL, Lazo JS, Parker KL, eds. The Pharmacological Basis of Therapeutics, Eleventh Edition. New York: McGraw-Hill, 2006; 1111-26.